Literature DB >> 15181671

The promise of empirical research in the study of informed consent theory and practice.

Laura A Siminoff1, Marie Caputo, Christopher Burant.   

Abstract

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2004        PMID: 15181671     DOI: 10.1023/b:hecf.0000031780.66472.f4

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


× No keyword cloud information.
  40 in total

Review 1.  Improving communication with cancer patients.

Authors:  L A Siminoff
Journal:  Oncology (Williston Park)       Date:  1992-10       Impact factor: 2.990

2.  Clinical research and the noninstitutional elderly: a model for subject recruitment.

Authors:  M A Leader; E Neuwirth
Journal:  J Am Geriatr Soc       Date:  1978-01       Impact factor: 5.562

3.  Ethical aspects of dementia research: informed consent and proxy consent.

Authors:  G A Sachs; C B Stocking; R Stern; D M Cox; G Hougham; R S Sachs
Journal:  Clin Res       Date:  1994-10

4.  Problems and prospects for health services research on provider-patient communication.

Authors:  T S Inui; W B Carter
Journal:  Med Care       Date:  1985-05       Impact factor: 2.983

5.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

Authors:  H A Llewellyn-Thomas; M J McGreal; E C Thiel; S Fine; C Erlichman
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

6.  Interactions between oncologists and patients during rounds.

Authors:  C G Blanchard; J C Ruckdeschel; E B Blanchard; J G Arena; N L Saunders; E D Malloy
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

7.  Cancer patients' decision making and trial-entry preferences: the effects of "framing" information about short-term toxicity and long-term survival.

Authors:  H A Llewellyn-Thomas; M J McGreal; E C Thiel
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

8.  Individual autonomy and the double-blind controlled experiment: the case of desperate volunteers.

Authors:  B P Minogue; G Palmer-Fernandez; L Udell; B N Waller
Journal:  J Med Philos       Date:  1995-02

9.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

10.  The elderly patient and informed consent. Empirical findings.

Authors:  B Stanley; J Guido; M Stanley; D Shortell
Journal:  JAMA       Date:  1984-09-14       Impact factor: 56.272

View more
  4 in total

1.  Coming Soon to a Physician Near You: Medical Neoliberalism and Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Harvard Health Policy Rev       Date:  2007

2.  Processes of consent in research for adults with impaired mental capacity nearing the end of life: systematic review and transparent expert consultation (MORECare_Capacity statement).

Authors:  C J Evans; E Yorganci; P Lewis; J Koffman; K Stone; I Tunnard; B Wee; W Bernal; M Hotopf; I J Higginson
Journal:  BMC Med       Date:  2020-07-22       Impact factor: 8.775

3.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

4.  Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.

Authors:  Jill A Fisher; Torin Monahan; Rebecca L Walker
Journal:  J Bioeth Inq       Date:  2019-11-12       Impact factor: 1.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.